Cardio-renal failure: An emerging clinical entity

Nephrology Dialysis Transplantation

Volumn 20, Issue 9, 2005, Pages 1780-1783

  Gil, Paloma ^a   Justo, Soledad ^a   Caramelo, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Anemia; Cardio renal insufficiency; Fluid equilibrium; Hidden renal failure; Personalized therapy; Risk of hyperkalemia

Indexed keywords

ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENKEPHALINASE INHIBITOR; ERYTHROPOIETIN; POTASSIUM; SPIRONOLACTONE;

ANEMIA; ARTICLE; BLOOD PRESSURE MONITORING; COMORBIDITY; CREATININE CLEARANCE; DIARRHEA; DISEASE ASSOCIATION; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SALT INTAKE; ULTRAFILTRATION;

AGING; COMORBIDITY; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE; MODELS, BIOLOGICAL;

EID: 23844553160     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh927     Document Type: Article

References (30)

1. Isles C. Cardiorenal failure. Pathophysiology, recognition and treatment. Clin Med 2002; 2: 195-200
2. McCollough PA. Cardiorenal risk: An important clinical intersection. Rev Cardiovasc Med 2002; 3: 71-76
3. Grupo de trabajo de la IC de la Sociedad Española de Medicina Interna. Insuficiencia cardiaca en los Servicios de Medicina Interna (estudio Semi-IC). Med Clin 16 2002; 118: 605-610
4. Cowie MR, Mosterd A, Wood DA et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-225
5. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109: 1004-1009
6. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme, ramipril, on cardiovascular events in high risk patients. The Heart Outcomes Evaluation Study Investigators. N Engl J Med 2000; 342: 145-153
7. Ruilope LM, Salvetti A, Jamerson K et al. Renal insufficiency and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol 2001; 12: 218-225
8. Mann DL. Mechanisms and models in heart failure: A combination approach. Circulation 1999; 100: 999-1008
9. Fried LF, Shlipak MG, Crump C et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41: 1364-1372
10. Muntner P, He J, Hamm L, Loira X, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753
11. Friedman PJ. Serum creatinine: An independent predictor of survival after stroke. J Intern Med 1991; 229: 175-179
12. Shlipak MG, Fried LF, Crump C et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 2002; 62: 997-1004
13. Henry RM, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn study. Kidney Int 2002; 62: 1402-1407
14. Goddard J, Johnston NR, Hand MF et al. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure. A comparison of selective and combined endothelin receptor blockade. Circulation 2004; 109: 1186-1193
15. Weinfeld MS, Chertow GM, Warner Stevenson L. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999; 138: 285-290
16. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med 2002; 347: 1256-1261
17. Al-Ahmad A, Rand WM, Manjunath G et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955-962
18. Russo D, Memoli B, Andreucci VE. The place of loop diuretics in the treatment of acute and chronic renal failure. Clin Nephrol 1992; 38 [Suppl 1]: S69-S73
19. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577-585
20. 2+ in vascular smooth muscle cells. Kidney Int 1990; 38: 47-54
21. Brammah A, Robertson S, Tait G, Isles C. Bilateral renovascular disease causing cardiorenal failure. Br Med J 2003; 326: 489-491
22. Wrenger E, Müller R, Moesenthin M, Welte T, Frölich JC, Neumann KH. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: Analysis of 44 cases. Br Med J 2003; 327: 147-149
23. Palmer B. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004; 351: 585-592
24. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality of patients with severe cardiac failure. N Engl J Med 1999; 341: 707-717
25. Juurlink DN, Mamdani MM, Lee DS et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004; 351: 543-551
26. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002; 13: 1928-1936
27. Al-Ahmad A, Rand WM, Manjunath G et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955-962
28. Van der Meer P, Voors AA, Lipsic E, Smilde TDJ, van Gilst WH, van Veldhuisen DJ. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 2004; 44: 63-67
29. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590
30. Sharma A, Hermann DD, Mehta RL. Clinical benefit and approach of ultrafiltration in acute heart failure. Cardiology 2001; 96: 144-154